Hepatitis B surface antigen (HBsAg) prevalence in Afghanistan
Afghanistan: Hepatitis B surface antigen (HBsAg) prevalence was 0.3% in 2024. ▼ Falling
Latest (2024)
0.3%
Change on year
unchanged
World rank
71st
of 194 countries
All-time high
0.4%
in 2015
All-time low
0.3%
in 2016
Years of data
10
2015–2024
Hepatitis B surface antigen (HBsAg) prevalence in Afghanistan, 2015–2024
Source: World Health Organization, Global Health Observatory.
Analysis
Afghanistan recorded 0.3% for hepatitis b surface antigen (hbsag) prevalence in 2024. That is the lowest value across all 10 years on record.
Compared with earlier readings it is down 25.0% over ten years.
Over the whole period, hepatitis b surface antigen (hbsag) prevalence in Afghanistan peaked at 0.4% in 2015 and was at its lowest, 0.3%, in 2016.
Afghanistan ranks 71st of 194 countries on this measure, in the middle of the range.
Hepatitis B surface antigen (HBsAg) prevalence in Afghanistan, year by year
| Year | Value | Change |
|---|---|---|
| 2015 | 0.4% | — |
| 2016 | 0.3% | -25.0% |
| 2017 | 0.3% | +0.0% |
| 2018 | 0.3% | +0.0% |
| 2019 | 0.3% | +0.0% |
| 2020 | 0.3% | +0.0% |
| 2021 | 0.3% | +0.0% |
| 2022 | 0.3% | +0.0% |
| 2023 | 0.3% | +0.0% |
| 2024 | 0.3% | +0.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 0.3% | 0.3% | 0.4% | 5 |
| 2020s | 0.3% | 0.3% | 0.3% | 5 |
Countries ranked near Afghanistan
- 71 Turkmenistan 0.3% compare
- 71 Uganda 0.3% compare
- 71 Azerbaijan 0.3% compare
- 71 Bosnia and Herzegovina 0.3% compare
- 71 Haiti 0.3% compare
- 71 Sri Lanka 0.3% compare
- 71 Republic of Moldova 0.3% compare
- 71 Mongolia 0.3% compare
- 71 Malawi 0.3% compare
- 71 Rwanda 0.3% compare
More health data for Afghanistan
- Un projection of annual infant deaths, annual growth rate -1.45 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 1.03 % change on previous year (2090)
- Heat deaths vs projected death rates 812.4 (2090)
- Un projection of annual infant deaths 14,735 (2100)
- Population ages 0-14, female, annual growth rate 2.05 % change on previous year (2025)
- Population ages 0-14, female, per unit of GDP 0.0005 units per US$ of GDP (2024)
- Population ages 0-14, female, per capita 0.2081 units per person (2025)
- Population ages 0-14, male, annual growth rate 1.99 % change on previous year (2025)
- Population ages 0-14, male, per unit of GDP 0.0005 units per US$ of GDP (2024)
- Population ages 0-14, male, per capita 0.2175 units per person (2025)
Frequently asked questions
- What is hepatitis b surface antigen (hbsag) prevalence in Afghanistan?
- Hepatitis b surface antigen (hbsag) prevalence in Afghanistan was 0.3% in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest hepatitis b surface antigen (hbsag) prevalence recorded in Afghanistan?
- The highest recorded value was 0.4% in 2015.
- What is the lowest hepatitis b surface antigen (hbsag) prevalence recorded in Afghanistan?
- The lowest recorded value was 0.3% in 2016.
- How does Afghanistan rank for hepatitis b surface antigen (hbsag) prevalence?
- Afghanistan ranks 71st out of 194 countries with data for 2024.
- Is hepatitis b surface antigen (hbsag) prevalence rising or falling in Afghanistan?
- Over the last ten years it is down 25.0%. The long-run trend across the full record is falling.
- Where does this Afghanistan data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 10 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).